Leading Drug Safety Expert Dr Stephen Revell Joins American HSC

Dec. 6, 2009 - PRLog -- American Health Systems Corporation (American HSC), a leading international Drug Safety and Pharmacovigilance service provider, is pleased to announce that Stephen Revell, MD, a leading authority on Drug Safety and Pharmacovigilance, has joined  American HSC as a managing partner.

Dr Alan Bess, President and CEO of American HSC said “Dr Revell has been on the cutting edge of international drug safety for over 15 years. He is a true leader and recognized expert in the field. His passion for Drug Safety is a perfect fit for American HSC and he will help take our organization to the next level”.

Dr Revell has extensive experience in clinical and post marketing drug safety and has been an invited speaker at numerous drug safety courses and has presented at many scientific meetings. He has had experience with both product withdrawal and product suspension and in this context has interacted with Regulatory Authorities in both the EU and US. In addition, his achievements include developing adverse event tracking systems, training courses, analysis of safety signals, review of individual safety report, and preparation of the safety sections for NDA submissions. He has authored and co-authored more than 25 publications, including multiple analyses of identified safety signals.
Dr Revell has held senior global executive positions in pharmacovigilance, medical affairs, and clinical research with Hoffmann-La Roche (Switzerland), Alza, Biogen Idec, and Acadia Pharmaceuticals, working both in Europe and the US. This experience has provided him with insight into both large pharma and small biotech working environments.

# # #

American HSC is an internationally recognized leader in Drug Safety, Pharmacovigilance, and Pharmacoepidemiology. Our mission is to provide a competitive advantage for our clients. American HSC delivers a unique combination of highly skilled and experienced drug safety experts, exclusive technology, and best practices in drug safety and pharmacovigilance.